Tumor heterogeneity and clonal cooperation influence the immune selection of IFN-γ-signaling mutant cancer cells

Jason B. Williams(Brigham and Women's Hospital), Thomas F. Gajewski(University of Chicago)

Nature Communications

January 30, 2020

10.1038/s41467-020-14290-4

Cited by 122

Related Papers

Impact of oncogenic pathways on evasion of antitumour immune responses

|Nature reviews. Cancer|2018|652

Imatinib for Melanomas Harboring Mutationally Activated or Amplified <i>KIT</i> Arising on Mucosal, Acral, and Chronically Sun-Damaged Skin

|Journal of Clinical Oncology|2013|594

Mechanism of tumor rejection with doublets of CTLA-4, PD-1/PD-L1, or IDO blockade involves restored IL-2 production and proliferation of CD8+ T cells directly within the tumor microenvironment

|Journal for ImmunoTherapy of Cancer|2014|543

Effect of Selumetinib vs Chemotherapy on Progression-Free Survival in Uveal Melanoma

|JAMA|2014|429

Epacadostat Plus Pembrolizumab in Patients With Advanced Solid Tumors: Phase I Results From a Multicenter, Open-Label Phase I/II Trial (ECHO-202/KEYNOTE-037)

|Journal of Clinical Oncology|2018|382